# Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy

> **NCT02027818** · PHASE2 · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 20 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT02027818
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02027818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02027818, "Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02027818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*